author-photo

Jens Hoffmann

Bayer Schering Pharma AG

4

Papers

73

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

In vitro characterization of ZK 230211—A type III progesterone receptor antagonist with enhanced antiproliferative properties

2010 The Journal of Steroid Biochemistry and Molecular Biology
Show All
- Source
- Cite
- Save
Citations (24)
Polymeric Micelles for parenteral delivery of Sagopilone: Physicochemical characterization, novel formulation approaches and their toxicity assessment in vitro as well as in vivo

2010 European Journal of Pharmaceutics and Biopharmaceutics
Show All
- Source
- Cite
- Save
Citations (25)
Sagopilone (ZK-EPO) inhibits bone destruction and tumor burden more efficiently than paclitaxel in a mouse model of established breast cancer bone metastasis

2008 Bone
Show All
- Source
- Cite
- Save
Citations (2)
Sagopilone (ZK-EPO): from a natural product to a fully synthetic clinical development candidate

2008 Expert Opinion on Investigational Drugs
Show All
- Source
- Cite
- Save
Citations (22)